DK1444356T3 - Identifikation af epitoper og mindskelse af allergeniciteten af fødevareproteiner - Google Patents
Identifikation af epitoper og mindskelse af allergeniciteten af fødevareproteinerInfo
- Publication number
- DK1444356T3 DK1444356T3 DK02795579.8T DK02795579T DK1444356T3 DK 1444356 T3 DK1444356 T3 DK 1444356T3 DK 02795579 T DK02795579 T DK 02795579T DK 1444356 T3 DK1444356 T3 DK 1444356T3
- Authority
- DK
- Denmark
- Prior art keywords
- epitopes
- identification
- allergenicity
- reduction
- food proteins
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- General Preparation And Processing Of Foods (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35065001P | 2001-11-13 | 2001-11-13 | |
| PCT/US2002/034879 WO2003042656A2 (en) | 2001-11-13 | 2002-10-30 | Identifying and reducing the allergenicity of food proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1444356T3 true DK1444356T3 (da) | 2012-08-13 |
Family
ID=23377621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02795579.8T DK1444356T3 (da) | 2001-11-13 | 2002-10-30 | Identifikation af epitoper og mindskelse af allergeniciteten af fødevareproteiner |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040209312A1 (da) |
| EP (1) | EP1444356B1 (da) |
| AT (1) | ATE557034T1 (da) |
| AU (1) | AU2002360330A1 (da) |
| DK (1) | DK1444356T3 (da) |
| WO (1) | WO2003042656A2 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005044838A2 (en) | 2003-11-03 | 2005-05-19 | Genencor International, Inc. | Cd4+ epitopes of bone morphogenetic proteins |
| ATE457458T1 (de) * | 2003-12-18 | 2010-02-15 | Genencor Int | Beta-lactamase-cd4+-t-zellepitope |
| EP1740952A2 (en) * | 2004-04-26 | 2007-01-10 | Genencor International, Inc. | Population based prediction methods for immune response determinations and methods for verifying immunological response data |
| WO2006097120A1 (en) * | 2005-03-15 | 2006-09-21 | Tred Srl | A process for the preparation of hypoallergenic alimentary proteins |
| FR2897942A1 (fr) * | 2006-02-28 | 2007-08-31 | Immogenics Ltd | Methode d'analyse de sang |
| US20140122184A1 (en) | 2012-10-29 | 2014-05-01 | Elwha Llc | Food Supply Chain Automation Grocery Information System And Method |
| US20140121807A1 (en) | 2012-10-29 | 2014-05-01 | Elwha Llc | Food Supply Chain Automation Farm Tracking System and Method |
| CN102940019B (zh) * | 2012-11-21 | 2016-05-18 | 中国农业大学 | 一种降低或脱除虾中过敏原的方法 |
| WO2014120810A1 (en) * | 2013-01-31 | 2014-08-07 | Elwha Llc | Food supply chain automation residential information system and method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6835550B1 (en) * | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| US20020009452A1 (en) * | 1999-02-10 | 2002-01-24 | Michael Caplan | Method for altering undesirable immune responses to polypeptides |
| AU3717600A (en) * | 1999-03-02 | 2000-09-21 | Board Of Trustees Of The University Of Arkansas, The | Methods and reagents for decreasing clinical reaction to allergy |
| AU2363301A (en) * | 1999-12-02 | 2001-06-12 | Thromb-X N.V. | Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes |
| US20030041354A1 (en) * | 2000-10-17 | 2003-02-27 | Novozymes A/S | Transgenic plants |
-
2002
- 2002-10-30 AT AT02795579T patent/ATE557034T1/de active
- 2002-10-30 AU AU2002360330A patent/AU2002360330A1/en not_active Abandoned
- 2002-10-30 WO PCT/US2002/034879 patent/WO2003042656A2/en not_active Application Discontinuation
- 2002-10-30 US US10/493,369 patent/US20040209312A1/en not_active Abandoned
- 2002-10-30 DK DK02795579.8T patent/DK1444356T3/da active
- 2002-10-30 EP EP02795579A patent/EP1444356B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1444356A4 (en) | 2005-08-10 |
| EP1444356B1 (en) | 2012-05-09 |
| ATE557034T1 (de) | 2012-05-15 |
| AU2002360330A1 (en) | 2003-05-26 |
| WO2003042656A2 (en) | 2003-05-22 |
| WO2003042656A3 (en) | 2004-03-04 |
| EP1444356A2 (en) | 2004-08-11 |
| US20040209312A1 (en) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
| EP1644416A4 (en) | ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES | |
| WO2003014325A3 (en) | Protein design automation for protein libraries | |
| ATE289640T1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
| IL211367A0 (en) | An antibody, a fragment thereof, a method of preparing the same and a use of the antibody | |
| ATE525913T2 (de) | Fettzusammensetzungen | |
| DK1545597T3 (da) | Immunstimulerende sammensætninger og fremgangsmåde til stimulering af en immunrespons | |
| ATE432067T1 (de) | Embolie-teilchen | |
| CY1116506T1 (el) | Αντισωματα εναντι masp-2 | |
| DK1255826T3 (da) | Automatisering af proteindesign for proteinbiblioteker | |
| TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| EA200601555A1 (ru) | Замещенные индазол-о-глюкозиды | |
| MY163480A (en) | Sclerostin binding agents | |
| TNSN05254A1 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics | |
| EA200601554A1 (ru) | Замещенные индол-о-глюкозиды | |
| WO2004007520A3 (en) | Methods and compositions for preventing oxidative degradation of proteins | |
| WO2005056759A3 (en) | Methods of generating variant proteins with increased host string content and compositions thereof | |
| WO2004091572A3 (en) | Cochleate compositions directed against expression of proteins | |
| AR038563A1 (es) | Composicion de ziprasidona y controles sinteticos | |
| DK1557462T3 (da) | Transplantataccept-inducerende celler af monocytisk oprindelse, deres fremstilling og anvendelse | |
| MXPA04005517A (es) | Composiciones farmaceuticas bajo forma de gel o solucion a base de dihidrotestosterona, su metodo de preparacion y sus usos. | |
| WO2003103571A3 (en) | VACCINES AGAINST FLAVIVIRUSES | |
| WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
| MXPA03010158A (es) | Sulfonamidas. |